Daniel M. Sullivan
Impact in
- Hematology top 0.5%
- Multiple Myeloma Research and Treatments
- Oncology top 1%
- Drug Transport and Resistance Mechanisms
- Cytokine Signaling Pathways and Interactions
Papers in
- Hematology 65
- Multiple Myeloma Research and Treatments 50
- Hematopoietic Stem Cell Transplantation 11
- Acute Myeloid Leukemia Research 4
-
- Cancer therapeutics and mechanisms 37
- Histone Deacetylase Inhibitors Research 7
- PI3K/AKT/mTOR signaling in cancer 5
- Nuclear Structure and Function 4
- Co-authors
- Joel G. Turner (27 shared papers)Pamela N. Münster (16 shared papers)ADIL I. DAUD (14 shared papers)Jana L. Dawson (20 shared papers)Douglas C. Marchion (11 shared papers)Elona Biçaku (8 shared papers)Warren E. Ross (6 shared papers)William S. Dalton (24 shared papers)
- Journals
- Blood (41 papers)Clinical Cancer Research (24 papers)Cancer Research (8 papers)Transplantation and Cellular Therapy (7 papers)Cancer Chemotherapy and Pharmacology (5 papers)
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
Daniel M. Sullivan
182 papers receiving 9.0k citations
Daniel M. Sullivan's Hit Papers
Peers
Comparison fields: 5 of 97
- Hematology 1.3k
- Oncology 1.2k
- Biotechnology 267
- Molecular Biology 2.6k
- Biological Psychiatry 38
Countries citing papers authored by Daniel M. Sullivan
This map shows the geographic impact of Daniel M. Sullivan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel M. Sullivan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel M. Sullivan more than expected).
Fields of papers citing papers by Daniel M. Sullivan
This network shows the impact of papers produced by Daniel M. Sullivan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel M. Sullivan. The network helps show where Daniel M. Sullivan may publish in the future.
Co-authors
The 25 scholars most cited alongside Daniel M. Sullivan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 185 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Phase I Trial of Interleukin-12 Plasmid Electroporation in Patients With Metastatic Melanoma Hit paper breakdown → | 2008 | 589 |
| 2 | 2011 | 492 | |
| 3 | 2006 | 490 | |
| 4 | 2011 | 311 | |
| 5 | 1987 | 265 | |
| 6 | 2006 | 213 | |
| 7 | 2007 | 200 | |
| 8 | 2005 | 183 | |
| 9 | 2006 | 164 | |
| 10 | 2004 | 163 | |
| 11 | 2007 | 161 | |
| 12 | 1986 | 160 | |
| 13 | 2014 | 160 | |
| 14 | 2014 | 153 | |
| 15 | 2009 | 150 | |
| 16 | 1992 | 149 | |
| 17 | 2016 | 144 | |
| 18 | 2008 | 141 | |
| 19 | Proliferation-dependent topoisomerase II content as a determinant of antineoplastic drug action in human, mouse, and Chinese hamster ovary cells. | 1987 | 139 |
| 20 | 2012 | 139 |
About Daniel M. Sullivan
Daniel M. Sullivan is a scholar working on Hematology, Molecular Biology, Oncology, Cancer Research and Pathology and Forensic Medicine, having authored 185 papers that have together received 9.4k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (50 papers), Cancer therapeutics and mechanisms (37 papers), Hematopoietic Stem Cell Transplantation (11 papers), Histone Deacetylase Inhibitors Research (7 papers), PI3K/AKT/mTOR signaling in cancer (5 papers), Acute Myeloid Leukemia Research (4 papers), Nuclear Structure and Function (4 papers) and Drug Transport and Resistance Mechanisms (4 papers). The work is most often cited by research in Hematology (1.3k citations), Oncology (1.2k citations), Biotechnology (267 citations), Molecular Biology (2.6k citations) and Biological Psychiatry (38 citations). Daniel M. Sullivan has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Joel G. Turner, Pamela N. Münster, ADIL I. DAUD, Jana L. Dawson, Douglas C. Marchion, Elona Biçaku, Warren E. Ross, William S. Dalton, Susan E. Minton and Michael D. Latham. Their work appears in journals such as Blood, Clinical Cancer Research, Cancer Research, Transplantation and Cellular Therapy and Cancer Chemotherapy and Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.